From the annual report 30/4: In the forthcoming year, submission of our final pre-market approval (PMA) application to the FDA, and the official publication of theSOLVE dataset in a peer-reviewed medical journal will be important milestones
If they have published it, it hasn't been announced to my knowledge, and going on the above I think there would be an announcement, even if it wasn't price sensitive.
From the annual report 30/4: In the forthcoming year, submission...
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.04 |
Change
-0.015(1.43%) |
Mkt cap ! $318.9M | |||
| Open | High | Low | Value | Volume |
| $1.06 | $1.06 | 99.0¢ | $247.4K | 242.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1337 | $1.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.06 | 17547 | 1 |
View Market Depth
| Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
| EBR (ASX) Chart |